ERBB2 and inflammatory breast carcinoma: Furthermore, the impact on surgical treatment after NST was investigated.<h4>Methods</h4>Women diagnosed with HER2-positive IBC, treated with NST and surgery, between 2010 and 2020, were selected from the Netherlands Cancer Registry.